ARID1A and malignant colon neoplasm: For example, Arid1a-deficient CAR-T cell therapy markedly suppressed tumor growth in mouse colon cancer models while the use of Arid1a inhibitor in vivo decreased anti-tumor efficacy (43, 69, 70).